US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by LeonaBio, Inc.

News headline image
LeonaBio to Participate in Cantor Global Healthcare Conference 2026
From LeonaBio, Inc.
Via GlobeNewswire
Tickers LONA
News headline image
LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update
From LeonaBio, Inc.
Via GlobeNewswire
Tickers LONA
News headline image
LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer
From LeonaBio, Inc.
Via GlobeNewswire
Tickers LONA
News headline image
LeonaBio Presents on ATH-1105 at 5th Annual ALS Drug Development Summit
From LeonaBio, Inc.
Via GlobeNewswire
Tickers LONA
News headline image
LeonaBio to Participate in Upcoming Medical and Industry Meetings in June
From LeonaBio, Inc.
Via GlobeNewswire
Tickers LONA
News headline image
LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update
From LeonaBio, Inc.
Via GlobeNewswire
Tickers LONA
News headline image
LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D.
From LeonaBio, Inc.
Via GlobeNewswire
Tickers LONA
News headline image
LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer
From LeonaBio, Inc.
Via GlobeNewswire
Tickers LONA
News headline image
Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data
From LeonaBio, Inc.
Via GlobeNewswire
Tickers LONA
News headline image
LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update
From LeonaBio, Inc.
Via GlobeNewswire
Tickers LONA
News headline image
LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer
From LeonaBio, Inc.
Via GlobeNewswire
Tickers LONA